These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10725633)

  • 1. Needle displacement during HDR brachytherapy in the treatment of prostate cancer.
    Damore SJ; Syed AM; Puthawala AA; Sharma A
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1205-11. PubMed ID: 10725633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold marker displacement due to needle insertion during HDR-brachytherapy for treatment of prostate cancer: a prospective cone beam computed tomography and kilovoltage on-board imaging (kV-OBI) study.
    Herrmann MK; Kertesz T; Gsänger T; Bloch E; Pollul G; Bouabdallaoui M; Strauss A; Herrmann M; Christiansen H; Wolff HA; Hess CF; Hille A
    Radiat Oncol; 2012 Feb; 7():24. PubMed ID: 22348595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report.
    Martinez AA; Pataki I; Edmundson G; Sebastian E; Brabbins D; Gustafson G
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):61-9. PubMed ID: 11163498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of needle displacement in multifraction high-dose-rate prostate brachytherapy: A prospective volumetric analysis and technical considerations.
    Peddada AV; Blasi OC; White GA; Monroe AT; Jennings SB; Gibbs GL
    Pract Radiat Oncol; 2015; 5(4):228-37. PubMed ID: 25543199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small tolerance for catheter displacement in high-dose rate prostate brachytherapy is necessary and feasible.
    Tiong A; Bydder S; Ebert M; Caswell N; Waterhouse D; Spry N; Camille P; Joseph D
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1066-72. PubMed ID: 19616901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial.
    Martinez A; Gonzalez J; Stromberg J; Edmundson G; Plunkett M; Gustafson G; Brown D; Yan D; Vicini F; Brabbins D
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1019-27. PubMed ID: 7493828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interfraction patient motion and implant displacement in prostate high dose rate brachytherapy.
    Fox CD; Kron T; Leahy M; Duchesne G; Williams S; Tai KH; Haworth A; Herschtal A; Foroudi F
    Med Phys; 2011 Nov; 38(11):5838-43. PubMed ID: 22047347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
    J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants.
    Kini VR; Edmundson GK; Vicini FA; Jaffray DA; Gustafson G; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):571-8. PubMed ID: 10078639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous automatic segmentation of multiple needles using 3D ultrasound for high-dose-rate prostate brachytherapy.
    Hrinivich WT; Hoover DA; Surry K; Edirisinghe C; Montreuil J; D'Souza D; Fenster A; Wong E
    Med Phys; 2017 Apr; 44(4):1234-1245. PubMed ID: 28160517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A power Doppler ultrasound method for improving intraoperative tip localization for visually obstructed needles in interstitial prostate brachytherapy.
    Orlando N; Snir J; Barker K; D'Souza D; Velker V; Mendez LC; Fenster A; Hoover DA
    Med Phys; 2023 May; 50(5):2649-2661. PubMed ID: 36846880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of catheter displacement and anatomical variations on the dose distribution in MRI-guided focal HDR brachytherapy for prostate cancer.
    Maenhout M; van der Voort van Zyp JRN; Borot de Battisti M; Peters M; van Vulpen M; van den Bosch M; Moerland MA
    Brachytherapy; 2018; 17(1):68-77. PubMed ID: 28579419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer.
    Yoshida K; Yamazaki H; Nose T; Shiomi H; Yoshida M; Mikami M; Takenaka T; Kotsuma T; Tanaka E; Kuriyama K; Harada Y; Tohda A; Yasunaga Y; Oka T
    Brachytherapy; 2010; 9(1):36-41. PubMed ID: 19736046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of craniocaudal catheter displacement between fractions in computed tomography-based high dose rate brachytherapy of prostate cancer.
    Kim Y; Hsu IJ; Pouliot J
    J Appl Clin Med Phys; 2007 Sep; 8(4):1-13. PubMed ID: 18449148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy.
    Mullokandov E; Gejerman G
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1063-71. PubMed ID: 15001246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
    Grills IS; Martinez AA; Hollander M; Huang R; Goldman K; Chen PY; Gustafson GS
    J Urol; 2004 Mar; 171(3):1098-104. PubMed ID: 14767279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric comparison between treatment plans of patients treated with low-dose-rate vs. high-dose-rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trial.
    Major T; Polgár C; Jorgo K; Stelczer G; Ágoston P
    Brachytherapy; 2017; 16(3):608-615. PubMed ID: 28325472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study.
    Pinkawa M; Fischedick K; Treusacher P; Asadpour B; Gagel B; Piroth MD; Borchers H; Jakse G; Eble MJ
    Radiother Oncol; 2006 Jan; 78(1):41-6. PubMed ID: 16271785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.